Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON26448Not yet recruiting
Randomised, double-blind trial of ropivacaine and sodium chloride in hypermenorrhea (2 arms), sponsored by Máxima Medisch Centrum. Primary endpoint: Pain intensity 1 minute into active ablation. Planned start Nov 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON26448.